Kainos Laboratories

Kainos Laboratories Dividend Coverage

Delisted

The Dividend Coverage Ratio of Kainos Laboratories (4556.T) as of Oct 29, 2026 is 4.34. In the previous year, Dividend Coverage Ratio was 4.76 — a change of -8.69% (lower).

Dividend Coverage

4.34

YoY

-8.69%

Last updated:

Dividend Coverage Ratio of Kainos Laboratories is 2025 4.34 . Dividend Coverage Ratio of Kainos Laboratories was 2024 4.76 . It decreases by -8.69% lower compared to the previous year.

The Kainos Laboratories Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2018
5.32 JPY
Jan 1, 2019
6.57 JPY
Jan 1, 2020
6.47 JPY
Jan 1, 2021
6.71 JPY
Jan 1, 2022
5.06 JPY
Jan 1, 2023
5.45 JPY
Jan 1, 2024
4.76 JPY
Jan 1, 2025
4.34 JPY
The Kainos Laboratories Dividend Coverage history
YEARDividend CoverageYoY
4.34-8.69%
4.76-12.62%
5.45+7.71%
5.06-24.64%
6.71+3.65%
6.47-1.50%
6.57+23.53%
5.32-10.29%
5.93+6.81%
5.55+34.13%
4.14-27.63%
5.72—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kainos Laboratories Stock analysis

What does Kainos Laboratories do? Kainos Laboratories Inc develops and manufactures pharmaceuticals, diagnostic reagents, and related chemical products for distribution and import/export. The company sells its products to healthcare providers, hospitals, and medical institutions within Japan and internationally. Its core offerings include prescription medications, diagnostic tools, and chemical compounds used in medical research and treatment. The business model relies on direct sales to medical facilities and global trade of its pharmaceutical and diagnostic solutions. Kainos Laboratories Inc focuses on the Japanese market with its headquarters in Bunkyo-Ku, Tokyo-To, while also engaging in international import/export activities. The company's revenue streams come from the sale of pharmaceuticals, diagnostic reagents, and chemical products to healthcare professionals and institutions. Its product portfolio targets medical practitioners and research organizations requiring specialized diagnostic and therapeutic solutions. The company operates with 144 full-time employees dedicated to the development, manufacturing, and distribution of its products. Kainos Laboratories Inc generates income through the commercialization of its pharmaceuticals and diagnostic reagents, serving both domestic and global clients in the healthcare sector. Sales are driven by demand for medical treatments and diagnostic tools in clinical and research settings. Kainos Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kainos Laboratories stock

Dividend Coverage Ratio of Kainos Laboratories is 4.34 in 2025.

Dividend Coverage Ratio of Kainos Laboratories changed from 4.76 to 4.34, representing a -8.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Kainos Laboratories since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Kainos Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Kainos Laboratories

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Kainos Laboratories